Abstract
The purpose of the systematic review is to review literature and synthesize current evidence on the use of cannabidiol in children (≤18 years old) with drug-resistant epilepsy.
Sigma Membership
Unknown
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Cannabidiol, Pediatric Drug Resistant Epilepsy, Systematic Review
Recommended Citation
Ruiz, Mary Anne, "A systematic review of cannabidiol as an adjunct treatment for pediatric drug-resistant epilepsy" (2020). INRC (Congress). 148.
https://www.sigmarepository.org/inrc/2020/posters_2020/148
Conference Name
31st International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Virtual Event
Conference Year
2020
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Review Type
Abstract Review Only: Reviewed by Event Host
Acquisition
Proxy-submission
A systematic review of cannabidiol as an adjunct treatment for pediatric drug-resistant epilepsy
Virtual Event
The purpose of the systematic review is to review literature and synthesize current evidence on the use of cannabidiol in children (≤18 years old) with drug-resistant epilepsy.